AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Anoglim M 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Aenor Pharmaceuticals Private Limited

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Anoglim M 2mg/500mg Tablet SR

Diabexe Duo 2mg/500mg Extended-Release Tablets are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by managing blood glucose levels. Diabexe Duo should be taken with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose levels and potentially serious complications, including kidney impairment, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential for prevention. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some patients. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended as directed by your physician.

Uses of Anoglim M 2mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Anoglim M 2mg/500mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing it. Anoglim M 2mg/500mg Sustained-Release Tablets should be administered with a meal.

Common Side effects of Anoglim M 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Anoglim M 2mg/500mg Tablet SR:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Anoglim M 2mg/500mg Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.

How Anoglim M 2mg/500mg Tablet SR works:

Anoglim M SR tablets (2mg/500mg) combine glimepiride and metformin, two agents used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thereby reducing blood sugar. Metformin, a biguanide, acts through multiple mechanisms: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Anoglim M 2mg/500mg SR tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Anoglim M 2mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. Prescribing this medication will involve a careful assessment of benefits against potential risks by your physician. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Prolonged-release Anoglim M 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Anoglim M 2mg/500mg SR tablets, as dose modification may be necessary. Consult your physician for guidance. Anoglim M 2mg/500mg SR tablets are contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Anoglim M 2mg/500mg Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, Anoglim M 2mg/500mg Tablet SR is typically initiated at a low dose; however, its use is contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Anoglim M 2mg/500mg Tablet SR :

Should you forget to take a dose of Anoglim M 2mg/500mg Extended-Release Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Anoglim M 2mg/500mg Tablet SR

LabelValue
Addictive None.
Medication Category Medication for diabetes

FAQs on Anoglim M 2mg/500mg Tablet SR

Retain this medication in its original, sealed container. Follow the storage guidelines provided on the packaging. Discard any leftover medicine. Ensure it remains inaccessible to children, pets, and others.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential consequence of taking Anoglim M 2mg/500mg Tablet SR. This adverse reaction, also termed Metformin-associated lactic acidosis (MALA), is infrequent but poses a significant risk to individuals with impaired kidney function, the elderly, or those who consume substantial alcohol. Symptoms can manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal discomfort, or bradycardia. Should these symptoms appear, discontinue Anoglim M 2mg/500mg Tablet SR and seek prompt medical attention.
Anoglim M 2mg/500mg sustained-release tablets contain glimepiride and metformin. This dual-agent medication manages type 2 diabetes mellitus in adults, enhancing glycemic control when combined with a healthy diet and physical activity. Glimepiride stimulates pancreatic insulin secretion, thus reducing blood glucose. Metformin reduces hepatic glucose production and increases insulin responsiveness. This formulation is unsuitable for type 1 diabetes mellitus.
Taking Anoglim M 2mg/500mg sustained-release tablets may result in common side effects such as low blood sugar, taste changes, queasiness, abdominal discomfort, loose stools, and cephalalgia. Rare but potentially severe adverse reactions include lactic acidosis. Prolonged administration may additionally cause vitamin B12 insufficiency.
Prolonged use of Anoglim M 2mg/500mg sustained-release tablets can lead to vitamin B12 deficiency. This medication impairs the body's absorption of vitamin B12 in the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications such as paresthesia in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and gait instability. Preventive measures, including supplemental vitamin B12, at least annually, are recommended by some experts.
Anoglim M 2mg/500mg SR tablets can induce hypoglycemia. Low blood sugar may manifest as nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The risk increases with skipped or delayed meals, alcohol consumption, strenuous physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice, is recommended.
Combining Anoglim M 2mg/500mg SR tablets with alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia). Concurrent use also elevates the likelihood of lactic acidosis.
Anoglim M 2mg/500mg Table...
44
MRP 53
16% off